Mechanism of action of the intrauterine contraceptive device: Evidence for a specific biochemical deficiency in the endometrium

Human Reproduction

Volumn 11, Issue 6, 1996, Pages 1220-1222

  Seleem, S ^a   Hills, F A ^b   Salem, H T ^a   El Nashar, E M ^a   Chard, T ^b,c  

^a ASSIUT UNIVERSITY   (Egypt)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Contraception; Endometrium; Intrauterine contraceptive device; Pregnancy proteins

Indexed keywords

PLACENTA PROTEIN 14; SOMATOMEDIN BINDING PROTEIN 1;

ARTICLE; BREAKTHROUGH BLEEDING; CONTRACEPTION; CONTRACEPTIVE DEVICE; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; NORMAL HUMAN;

EID: 0030036950     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019359     Document Type: Article

References (23)

1. Belhadj, H., Sivin, I., Diaz, S. et al. (1986) Recovery of fertility after use of the levonorgestrel 20 mcg/day or copper T380 Ag intrauterine device. Contraception, 34, 261-267.
2. Bolton, A.E., Clough, K.J., Stoker, R.J. et al. (1987) Identification of placental protein 14 as an immunosuppressive factor in human reproduction. Lancet, i, 593-595.
3. Chard, T. (1994) Insulin-like growth factors and their binding proteins in the control of human fetal growth. In Ward, R.H.T., Smith, S.K. and Donnai, D. (eds), Early Fetal Growth and Development. RCOG Press, London, pp. 293-308.
4. Chard, T. and Olajide, F. (1994) Endometrial protein PP14: a new test of endometrial function? Reprod. Med. Rev., 3, 43-52.
5. Connell, E.B. (1979) Contraception: Current Therapy. WB Saunders, Philadelphia.
6. Dalton, C.F., Laird, S.M., Serle, E. et al. (1995) The measurement of CA 125 and placental protein 14 in uterine flushings in women with recurrent miscarriage; relation to endometrial morphology. Hum. Reprod., 10, 2680-2684.
7. Howell, R.J.S., Olajide, F., Teisner, B. et al. (1989) Circulating levels of placental protein 14 and progesterone following Mifepristone (RU38486) and Gemeprost for termination of first trimester pregnancy. Fertil. Steril., 52, 66-68.
8. Joshi, S.G., Rao, R. and Henriques, E.E. (1986) Luteal-phase concentration of a progestogen-associated endometrial protein (PEP) in the serum of cycling women with adequate or inadequate endometrium. J. Clin. Endocrinol. Metab., 63, 1247-1251.
9. Julkunen, M., Seppala, M. and Janne, O.A. (1988) Complete amino acid sequence of human placental protein 14: a progesterone regulated uterine protein homologous to beta-lacto-globulins. Proc. Natl. Acad. Sci. USA, 85, 8845-8849.
10. Liskin, L. and Fox, G. (1982) IUDs: an appropriate contraceptive for many women. Population Rep. Series B, 4, 101-135.
11. Newton, J. and Tacchi, D. (1990) Long-term use of copper intrauterine devices. Lancet, 335, 1322-1323.
12. Pockley, A.G., Mowles, E.A. and Stoker, R.J. (1988) Suppression of in vitro lymphocyte reactivity to phytohemagglutinin by placental protein 14. J. Reprod. Immunol., 13, 31-39.
13. Segal, S.J., Alvarez-Sanchez, F. Adjuwon, C.A. et al. (1985) Absence of chorionic gonadotropin in sera of women who use intrauterine devices. Fertil. Steril., 44, 214-218.
14. Seppala, M., Riitinen, L. and Julkunen, M. (1988) Structural studies, localization in tissue and clinical aspects of human endometrial proteins. J. Reprod. Fertil. 36, 127-131.
15. Singh, A., Hamilton-Fairley, D., Koistinen, R. et al. (1990) Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. J. Endocrinol., 124, R1-R3.
16. Sivin, I. and Schmidt, F. (1987) Effectiveness of IUDs: contraception. Contraception, 36, 55-84.
17. Suikkari, A.M., Koivisto, V.A., Rutanen, E.M. et al. (1988) Insulin regulates serum levels of low molecular weight insulin-like growth factor binding protein. J. Clin. Endocrinol. Metab., 66, 266-274.
18. Thraikill, K.M., Clemmons, D.R., Busby, W.H. and Handwerger, S. (1990) Differential regulation of insulin-like growth factor binding protein secretion from human decidual cells. J. Clin. Invest., 26, 878-883.
19. Van Bogaert, L.J. (1983) A clinicopathological study of IUD users with special reference to endometrial patterns and endometritis. Gynecol. Obstet. Invest., 16, 129-136.
20. Vessey, M., Meisler, L., Flavel, R. and Yeates, D. (1979) Outcome of pregnancy in women using different methods of contraception. Br. J. Obstet. Gynaecol., 86, 548-556.
21. Wang, H.S., Perry, L.A., Kanisius, J. et al. (1991) Purification and assay of insulin-like growth factor-binding protein-1: measurement of circulating levels throughout pregnancy. J. Endocrinol, 128, 161-168.
22. Wilcox, A.J., Weinberg, C.R., Armstrong, E.G. and Canfield, R.E. (1987) Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay. Fertil. Steril., 47, 265-269.
23. Wood, P.L., Iffland, C.A., Allen, E. et al. (1990) Serum levels of pregnancy-associated endometrial I2-globulin (I2-PEG), a glycosylated β-lactoglobulin homologue, in successful and unsuccessful assisted conception. Hum. Reprod., 5, 421-426.